These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 6244392

  • 21. The effect of histamine, isoproterenol and tyramine on rat uterine cyclic AMP.
    Verma SC, McNeill JH.
    Res Commun Chem Pathol Pharmacol; 1976 Jan; 13(1):55-64. PubMed ID: 176705
    [Abstract] [Full Text] [Related]

  • 22. The effect of interaction between (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R)-ACPD and noradrenaline on cyclic AMP accumulation: different actions in brain slices, primary glial and neuronal cell cultures.
    Pilc A, Legutko B, Frankiewicz T, Czyrak A.
    Pol J Pharmacol; 1995 Jan; 47(1):75-9. PubMed ID: 7550553
    [Abstract] [Full Text] [Related]

  • 23. Norepinephrine-stimulated cyclic AMP accumulation in brain slices in vitro after serotonin depletion or chronic administration of selective amine reuptake inhibitors.
    Schmidt MJ, Thornberry JF.
    Arch Int Pharmacodyn Ther; 1977 Sep; 229(1):42-51. PubMed ID: 201222
    [Abstract] [Full Text] [Related]

  • 24. Interaction of clonidine with pre- and post-synaptic adrenergic receptors of rat brain: effects on cyclic AMP-generating systems.
    Skolnick P, Daly JW.
    Eur J Pharmacol; 1976 Sep; 39(1):11-21. PubMed ID: 183964
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Demonstration of inhibition of cyclic AMP accumulation in brain by very low concentrations of lithium in the presence of alpha-adrenoceptor blockade.
    Mármol F, Carbonell L, Cuffí ML, Forn J.
    Eur J Pharmacol; 1992 May 12; 226(1):93-6. PubMed ID: 1356811
    [Abstract] [Full Text] [Related]

  • 27. The noradrenergic cyclic AMP generating system in the limbic forebrain: pharmacological characterization in vitro and possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics.
    Blumberg JB, Vetulani J, Stawarz RJ, Sulser F.
    Eur J Pharmacol; 1976 Jun 12; 37(2):357-66. PubMed ID: 8317
    [Abstract] [Full Text] [Related]

  • 28. Lithium effects on noradrenergic-linked adenylate cyclase activity in intact rat brain: an in vivo microdialysis study.
    Masana MI, Bitran JA, Hsiao JK, Mefford IN, Potter WZ.
    Brain Res; 1991 Jan 11; 538(2):333-6. PubMed ID: 1849439
    [Abstract] [Full Text] [Related]

  • 29. [Lithium as a psychotropic drug. Experimental studies on its mechanism of action].
    Berndt S.
    Fortschr Med; 1982 Mar 11; 100(10):409-13. PubMed ID: 6279477
    [Abstract] [Full Text] [Related]

  • 30. Muscarinic cholinergic receptor-mediated control of cyclic AMP metabolism. Agonist-induced changes in nucleotide synthesis and degradation.
    Meeker RB, Harden TK.
    Mol Pharmacol; 1983 Mar 11; 23(2):384-92. PubMed ID: 6300648
    [Abstract] [Full Text] [Related]

  • 31. Cyclic nucleotides in mental disorder.
    Belmaker RH, Zohar J, Ebstein RP.
    Adv Cyclic Nucleotide Res; 1980 Mar 11; 12():187-98. PubMed ID: 6250353
    [Abstract] [Full Text] [Related]

  • 32. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
    Thomas NJ, Carcillo JA, Herzer WA, Mi Z, Jackson EK.
    J Pharmacol Exp Ther; 2001 Jan 11; 296(1):168-74. PubMed ID: 11123377
    [Abstract] [Full Text] [Related]

  • 33. Xylamine, an irreversible inhibitor of norepinephrine uptake, is transported by this same uptake mechanism in cultured rat superior cervical ganglia.
    Fischer JB, Waggaman LA, Ransom RW, Cho AK.
    J Pharmacol Exp Ther; 1983 Sep 11; 226(3):650-5. PubMed ID: 6887005
    [Abstract] [Full Text] [Related]

  • 34. Effect of morphine on catecholamine - stimulated cyclic AMP production in cortex slices from rats and mice.
    Slater P, Blundell C.
    J Neurosci Res; 1981 Sep 11; 6(6):701-8. PubMed ID: 6278156
    [Abstract] [Full Text] [Related]

  • 35. Adenosine--norepinephrine interactions on cyclic AMP generating system in human tumoral brain slices.
    Caciagli F, Ciccarelli R, Ciancetta S, Di Iorio P, Caciagli P.
    Int J Tissue React; 1982 Sep 11; 4(3):233-41. PubMed ID: 6292078
    [Abstract] [Full Text] [Related]

  • 36. Norepinephrine stimulation of pineal cyclic AMP response element-binding protein phosphorylation: primary role of a beta-adrenergic receptor/cyclic AMP mechanism.
    Roseboom PH, Klein DC.
    Mol Pharmacol; 1995 Mar 11; 47(3):439-49. PubMed ID: 7700241
    [Abstract] [Full Text] [Related]

  • 37. A comparative study on the effects of tetracyclines and lithium on the cyclic AMP second messenger system in rat brain.
    Mørk A, Geisler A.
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jan 11; 19(1):157-69. PubMed ID: 7708928
    [Abstract] [Full Text] [Related]

  • 38. Cyclic AMP in the rat cerebral cortex after activation of noradrenaline neurons of the locus coeruleus.
    Van der Heyden JA, Sebens JB.
    J Neurochem; 1979 Feb 11; 32(2):463-8. PubMed ID: 216776
    [No Abstract] [Full Text] [Related]

  • 39. Treatment with the type IV phosphodiesterase inhibitor Ro 20-1724 protects renal and mesenteric blood flow in endotoxemic rats treated with norepinephrine.
    Carcillo JA, Herzer WA, Mi Z, Thomas NJ, Jackson EK.
    J Pharmacol Exp Ther; 1996 Dec 11; 279(3):1197-204. PubMed ID: 8968341
    [Abstract] [Full Text] [Related]

  • 40. Noradrenergic subsensitivity and supersensitivity of the cerebral cortex after reserpine treatment.
    Palmer DS, French SW, Narod ME.
    J Pharmacol Exp Ther; 1976 Jan 11; 196(1):167-71. PubMed ID: 173828
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.